^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
nivatrotamab (GD2xCD3)
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Memorial Sloan-Kettering Cancer Center, Y-mAbs Therap
Drug class:
CD3 agonist, GD2 ganglioside inhibitor
Related drugs:
